Federal Register of Legislation - Australian Government

Primary content

PB 7 of 2011 Determinations/Health as made
This Determination amends the National Health Act 1953 - Determination under section 84AH - Exempt items (No. PB 58 of 2007) which determines the exempt status of a pharmaceutical item which has a particular form and manner of administration listed on the Pharmaceutical Benefits Scheme (PBS) by adding one drug and also amends the description of another which meet the criteria under section 84AH.
Administered by: Health
Registered 19 Jan 2011
Tabling HistoryDate
Tabled HR08-Feb-2011
Tabled Senate08-Feb-2011
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

COMMONWEALTH OF AUSTRALIA

Instrument number PB 7 of 2011

Amendment Determination under section 84AH of the National Health Act 1953

 

I, FELICITY McNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing make this instrument under section 84AH of the National Health Act 1953.

Dated                              17             January 2011

 

FELICITY McNEILL

 

Acting First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health and Ageing

 

Amendment Determination – exempt items

 

 

1         Commencement

 

This instrument commences on 20 January 2011.

 

 

   2        Amendment of PB 58 of 2007

 

                            Schedule 1 amends PB 58 of 2007.


Schedule 1                                 Amendments

 

 

 

[1]     Schedule 1, after item dealing with Oestradiol

                  

Insert in the columns in the order indicated:

 

Ondansetron

Syrup, 4 mg per 5 mL, 50 mL

Oral

 

 

 

 

[2]     Schedule 1, after item dealing with Valproic Acid

                  

Omit in the columns in the order indicated:

 

Valproic Acid

Oral solution (syrup) containing sodium valproate 200 mg per 5mL, 300 mL

Oral

 

 

 

 

Insert in the columns in the order indicated:

Valproic Acid

Oral solution containing sodium valproate 200 mg per 5mL, 300 mL

Oral

 

 

 

 

 

 

 

 

 

 

                                         

 

 

 

 

 

 

 

 

 

 

 

 

Note

1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.